Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Lilly Buying Spree Surpasses $32B

Bloomberg’s Madison Muller joins Dani Burger on “Bloomberg Deals.” Eli Lilly agreed to buy closely held Calytrix Bio in a deal that could be worth up to $1.5 billion, the latest in the drugmaker’s $32 billion wave of acquisitions in 2026 as it builds out its cancer and immunology businesses. (Source: Bloomberg)

We haven't written up this one. Bloomberg has the full story — the link below goes straight to it.

Read the original at bloomberg.com →

More in Finance & Markets

More from Wednesday 18 November →